Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia

Part of paid clinical trials in Hartford, Connecticut.

Sponsor
Memorial Sloan Kettering Cancer Center
Study ID
NCT02677064
Status
Recruiting
Apply to this trial

Conditions

  • Acute Leukemia
  • Newly Diagnosed
  • Relapsed

Eligibility Criteria

Sex
ALL
Age
18 Years - 80 Years
Healthy Volunteers
Not accepted

Interventions

  • assessments — OTHER
    All laboratory assessments performed on this study represent standard of care at our institution. HLA allele typing is performed by the center's HLA laboratory according to standard typing procedures.

Study Details

The investigators are doing this research study to assess the percentage of patients receiving stem cell transplantation for the type of blood cancer you have. They want to know how many patients get a transplant and why some patients do get a transplant while others do not. Also they want to explore why some patients elect not to undergo stem cell transplantation, when it is recommended by their physicians.

Key Dates

Start date
Feb 29, 2016
Status verified
Jan 2026
Primary completion
Feb 28, 2027
Completion
Feb 28, 2027

Study Design

Enrollment
1,365 participants (estimated)

Arms

  • Arm: Patients with Acute Leukemia (Arm A)
    Follow patients throughout their journey and identify prospectively the reasons why patients did not proceed to HCT when deemed appropriate and eligible.
  • Arm: Patients with MDS and MPN (Arm B)
    Follow patients throughout their journey and identify prospectively the reasons why patients did not proceed to HCT when deemed appropriate and eligible.
  • Arm: Patients with Acute Leukemia or MDS/MPN who Relapse After First Allografts (Arm C)
    Follow patients throughout their journey and identify prospectively the reasons why patients did not proceed to HCT when deemed appropriate and eligible.

Primary Outcome Measure

number of patients who proceed to transplant [ Time Frame: 3 years ]

Central Contacts

Locations (3)

FacilityCityStateZIPSite coordinators
Hartford Healthcare Cancer Institute @ Hartford HospitalHartfordConnecticut06102
Mark Dailey, MD
860-249-6291
Memorial Sloan Kettering Cancer CenterNew YorkNew York10065
Roni Tamari, MD
[email protected]
Sergio Giralt, MD
[email protected]
Lehigh Valley Health NetworkAllentownPennsylvania18103-

Find similar trials in Hartford, CT

By research site
Hartford Healthcare Cancer Institute @ Hartford Hospital· Hartford, CTMemorial Sloan Kettering Cancer Center· New York, NYLehigh Valley Health Network· Allentown, PA

Related Studies